COVID-19: High-JAKing of the Inflammatory “Flight” by Ruxolitinib to Avoid the Cytokine Storm

Since SARS-CoV-2 outbreak in December 2019, world health-system has been severely impacted with increased hospitalization, Intensive-Care-Unit (ICU) access and high mortality rates, mostly due to severe acute respiratory failure and multi-organ failure. Excessive and uncontrolled release of proinfla...

Descripción completa

Detalles Bibliográficos
Autores principales: Botta, Cirino, Indrieri, Alessia, Garofalo, Eugenio, Biamonte, Flavia, Bruni, Andrea, Pasqua, Pino, Cesario, Francesco, Costanzo, Francesco Saverio, Longhini, Federico, Mendicino, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819896/
https://www.ncbi.nlm.nih.gov/pubmed/33489899
http://dx.doi.org/10.3389/fonc.2020.599502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819896/
https://www.ncbi.nlm.nih.gov/pubmed/33489899
http://dx.doi.org/10.3389/fonc.2020.599502

Ejemplares similares